You are here: Home » Politics » News » National
Business Standard

Who will take vaccine with question marks on its reliability: Manish Tewari

Congress leader Manish Tewari said that the Bharatiya Janata Party (BJP) government has "politically misused" the Covid-19 pandemic and raised question marks on the reliability of the vaccine

Manish Tewari | Congress | Bharatiya Janata Party

ANI  |  Politics 

Manish Tewari
File photo of Manish Tewari

leader on Tuesday said that the (BJP) government has "politically misused" the COVID-19 pandemic and raised question marks on the reliability of the vaccine.

"The BJP government has politically misused the COVID-19 pandemic in its entirety. The controversy over the vaccine is its latest manifestation. Who is going to get himself vaccinated with a vaccine that has question marks on its reliability," Tewari said.

"The BJP govt has done a great disservice to that company which must have invested crores of rupees in research and development. In their quest to prove their 'Atmanirbhar Bharat' they have licensed a vaccine whose phase III trials are not complete," he added.

Earlier on January 2, Akhilesh Yadav had said that he will not get vaccinated against for now as the "BJP government cannot be trusted".

Meanwhile, Serum Institute of India and Bharat Biotech jointly communicated their pledge on Tuesday for the smooth rollout of COVID-19 vaccines to India and the world.

"Mr. Adar Poonawala and Dr. Krishna Ella, jointly on behalf of the two companies, today communicated their combined intent to develop, manufacture and supply the COVID-19 vaccines for India and globally," read a joint statement from SII and Bharat Biotech.

Adar Poonawala is Chief Executive Officer of SII. Dr. Krishna Ella is Chairman and Managing Director of Bharat Biotech.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, January 06 2021. 07:08 IST